tm
Seeing Is Believing
tm
Seeing Is Believing
Aptevo Therapeutics's activity chart (see below) currently has 9 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 21.43% with an average time for these price targets to be met of 459 days.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 23-Sep-2024. First documented stock forecast 05-Nov-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Mar-2020
$1172159.75
1 years 9 months 24 days ago
(23-Sep-2024)
0/4 (0%)
$172159.77 (17.22%)
Buy Since 28-Feb-2020
$423280
$423275.44 (9302757.00%)
3 years 11 months 5 days ago
(12-Aug-2022)
3/7 (42.86%)
$-576720 (-57.67%)
918
Buy Since 05-Nov-2018
$2083840
$2083835.5 (45698144.00%)
5 years 8 months 8 days ago
(09-Nov-2020)
0/1 (0%)
$1083840 (108.38%)
What is APVO (Aptevo Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on APVO (Aptevo Therapeutics) with a proven track record?
Which analyst has the current lower performing score on APVO (Aptevo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on APVO (Aptevo Therapeutics)?
Which analyst is the currently most bullish on APVO (Aptevo Therapeutics)?
Which analyst is the currently most reserved on APVO (Aptevo Therapeutics)?
